{
    "ticker": "BRTX",
    "name": "BriaCell Therapeutics Corp.",
    "description": "BriaCell Therapeutics Corp. is a biotechnology company dedicated to the development of innovative immunotherapy treatments for cancer. Founded in 2008 and headquartered in Vancouver, Canada, BriaCell is committed to advancing its lead product candidate, Bria-IMT, a personalized immunotherapy designed to enhance the immune system's ability to target and destroy cancer cells. This approach is particularly focused on treating advanced breast cancer, a condition that affects many women worldwide. The company's research is rooted in pioneering scientific advancements in immuno-oncology, aiming to provide patients with safer and more effective treatment options compared to traditional chemotherapy. BriaCell is also exploring collaborations with various research institutions and pharmaceutical companies to further its research and development efforts. With a dedicated team of scientists and researchers, BriaCell is at the forefront of cancer treatment innovation, striving to improve patient outcomes and quality of life through its groundbreaking therapies. The company's mission is to harness the power of the immune system to fight cancer, ultimately seeking to make a transformative impact in the field of oncology.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Vancouver, British Columbia, Canada",
    "founded": "2008",
    "website": "https://www.briacell.com",
    "ceo": "Dr. Bill Williams",
    "social_media": {
        "twitter": "https://twitter.com/BriaCell",
        "linkedin": "https://www.linkedin.com/company/briacell-therapeutics-corp/"
    },
    "investor_relations": "https://www.briacell.com/investor-relations",
    "key_executives": [
        {
            "name": "Dr. Bill Williams",
            "position": "CEO"
        },
        {
            "name": "Dr. A. D. M. M. Wong",
            "position": "Chief Scientific Officer"
        }
    ],
    "product_categories": [
        {
            "category": "Cancer Immunotherapy",
            "products": [
                "Bria-IMT"
            ]
        }
    ],
    "seo": {
        "meta_title": "BriaCell Therapeutics Corp. | Innovative Cancer Immunotherapy",
        "meta_description": "Explore BriaCell Therapeutics Corp., a leader in cancer immunotherapy focused on developing treatments for advanced breast cancer. Discover our innovative approach to harnessing the immune system.",
        "keywords": [
            "BriaCell",
            "Immunotherapy",
            "Cancer Treatment",
            "Breast Cancer",
            "Biotechnology",
            "Pharmaceuticals"
        ]
    },
    "faq": [
        {
            "question": "What is BriaCell Therapeutics known for?",
            "answer": "BriaCell Therapeutics is known for developing innovative immunotherapy treatments for cancer, particularly advanced breast cancer."
        },
        {
            "question": "Who is the CEO of BriaCell?",
            "answer": "Dr. Bill Williams is the CEO of BriaCell Therapeutics Corp."
        },
        {
            "question": "Where is BriaCell headquartered?",
            "answer": "BriaCell is headquartered in Vancouver, British Columbia, Canada."
        },
        {
            "question": "What is Bria-IMT?",
            "answer": "Bria-IMT is BriaCell's lead product candidate, designed to enhance the immune system's ability to fight cancer."
        },
        {
            "question": "When was BriaCell founded?",
            "answer": "BriaCell was founded in 2008."
        }
    ],
    "competitors": [
        "KITE",
        "BMY",
        "NVS",
        "AMGN"
    ],
    "related_stocks": [
        "GILD",
        "MRNA",
        "REGN",
        "VRTX"
    ]
}